Cardiology – Page 4

Derivation and Validation of Claims-Based Operational Definitions for Cardiogenic Shock: Enhancing Diagnostic Accuracy and Epidemiologic Surveillance

By MedXY 10/14/2026

This review synthesizes evidence on the derivation and validation of a claims-based algorithm for identifying cardiogenic shock (CS), demonstrating its high diagnostic performance and enabling robust large-scale epidemiologic and long-term outcome research.

Cardiology Emergency Medicine news

Outcomes and Diagnostic Spectrum of Paramedic-Suspected STEMI: Insights from a Statewide Registry

By MedXY 10/14/2026

Paramedic-suspected STEMI identified a heterogeneous, high-acuity population where 60% had confirmed STEMI; outcomes vary by final diagnosis, underscoring the need for rapid reperfusion with early diagnostic refinement.

Cardiology news

Reducing Heat-Related Harm in People with Heart Disease: Key Recommendations from the 2026 European Heart Journal Consensus

By MedXY 10/13/2026

An expert consensus provides practical, evidence-informed guidance for clinicians to protect people with cardiovascular disease from rising heat extremes, focusing on prevention, medication review, cooling strategies, and health-system preparedness.

Cardiology news Pediatrics

Sotatercept as Add-On Therapy in Pediatric Pulmonary Hypertension: Promising Outcomes from the Pediatric Pulmonary Hypertension Network

By MedXY 10/11/2026

Retrospective multi-center data demonstrate that sotatercept improves functional status, exercise capacity, and hemodynamics in children with pulmonary hypertension, with a manageable safety profile.

Cardiology news Ophthalmology

PCSK9 Inhibitors and Their Protective Role Against Retinal Vascular Occlusions in Hyperlipidemic Patients

By MedXY 10/11/2026

PCSK9 inhibitors significantly reduce the risk of retinal vascular occlusions compared to other lipid-lowering therapies in patients with hyperlipidemia, highlighting their potential as a neuroprotective cardiovascular intervention.

Cardiology Nephrology news

Unveiling TBX2: A Master Regulator of Vascular Calcification in Chronic Kidney Disease

By MedXY 10/11/2026

TBX2 is identified as a key transcription factor repressing vascular calcification by controlling RUNX2 and the inflammatory NLRP3 pathway, highlighting new therapeutic targets to reduce cardiovascular risk in CKD.

$Dual Antiglutamate Therapy in Super-Refractory Status Epilepticus After Cardiac Arrest: Insights from the SUPER-CAT Study and Current Evidence$

Cardiology Clinical Updates news

Dual Antiglutamate Therapy in Super-Refractory Status Epilepticus After Cardiac Arrest: Insights from the SUPER-CAT Study and Current Evidence

By MedXY 10/10/2026

This review synthesizes evidence on dual antiglutamate therapy combining AMPA and NMDA receptor blockade in postanoxic super-refractory status epilepticus, highlighting the SUPER-CAT study's demonstration of improved seizure resolution and clinical outcomes.

Cardiology news

From Cath Lab Curiosity to Guideline Mandate: How Intravascular Imaging Became Essential for Complex PCI

By MedXY 10/10/2026

Recent guideline updates elevate intravascular ultrasound (IVUS) and optical coherence tomography (OCT) from optional tools to Class I, Level A strategies for many complex percutaneous coronary interventions, driven by randomized trials and pooled analyses showing better stent results and improved clinical outcomes.

Cardiology news

Conduction System Pacing vs Biventricular Pacing After AV Node Ablation in AF with Heart Failure: Insights from the CONDUCT-AF Trial

By MedXY 10/10/2026

The CONDUCT-AF trial demonstrated that conduction system pacing is non-inferior to biventricular pacing for improving LVEF at 6 months in patients with refractory AF and HF undergoing AV node ablation, with procedural advantages favoring CSP.

Cardiology news

Adults with Congenital Heart Disease: Unveiling the Impact of Acquired Cardiovascular Risk Factors on Long-Term Survival

By MedXY 10/10/2026

A large cohort study highlights how acquired cardiovascular risk factors significantly influence late mortality in adults with congenital heart disease, underscoring the need for integrated care strategies.

Cardiology Critical Care news

In-Hospital Cardiac Arrest in China: Incidence, Care Processes, and Survival Outcomes in a Multicenter Prospective Study

By MedXY 10/10/2026

This multicenter Chinese registry study reveals a high incidence of in-hospital cardiac arrest with low survival rates and highlights critical gaps in postresuscitation care and systemic factors limiting outcomes.

Cardiology news

Oxidized Phospholipid PGPC Impedes Angiogenesis by Disrupting Endothelial Autophagy via NPC1-Mediated Syntaxin 17 Modification

By MedXY 10/10/2026

The oxidized phospholipid PGPC inhibits angiogenesis in ischemic heart disease by impairing endothelial autophagic flux through NPC1-induced acetylation and ubiquitination of syntaxin 17, unveiling new potential therapeutic targets for coronary artery disease.

Cardiology news

Optimizing Coronary Intervention: Lipid Core Burden Index Identifies Vulnerable Plaques Benefiting from Preventive PCI in PREVENT Trial Analysis

By MedXY 10/10/2026

This post hoc analysis of the PREVENT trial highlights that preventive PCI significantly reduces adverse cardiac events in patients with vulnerable lipid-rich plaques, identified by near-infrared spectroscopy, underscoring the importance of plaque composition in guiding intervention.

Cardiology news Respiratory

Occupational Dust and Fume Exposure Elevates Risk of Respiratory and Cardiovascular Complications in Smokers

By MedXY 10/09/2026

Occupational exposure to both dust and fumes significantly increases the risk of future respiratory exacerbations, atherosclerotic cardiovascular disease, and pneumonia in smokers and former smokers, underscoring the need for targeted preventive strategies.

Cardiology Neurology news

Assessing Early Catheter Ablation in Atrial Fibrillation Patients With Prior Stroke: Insights From a Target Trial Emulation

By MedXY 10/07/2026

Early catheter ablation in atrial fibrillation patients with prior ischemic stroke reduces major adverse cardiovascular events and improves neurological and cognitive outcomes compared to medical therapy, according to a multi-center retrospective target trial emulation.

Cardiology Diabetes & Endocrinology news

Functional Hypothalamic Amenorrhea Phenotype and Cardiovascular Disease Risk

By MedXY 10/07/2026

Functional hypothalamic amenorrhea (FHA) in mid-adulthood is linked to increased coronary heart disease risk and type 2 diabetes, independent of traditional factors, highlighting menstrual irregularities as early cardiometabolic risk indicators.

Cardiology Hematology-Oncology news

Unraveling the Mechanistic Role of Syndecan-4 and Piezo1 in Deep Vein Thrombosis: Therapeutic Insights from Quercetin

By MedXY 10/07/2026

This study reveals that syndecan-4 shedding exacerbates deep vein thrombosis by promoting Piezo1-dependent endothelial-mesenchymal transition, with quercetin showing promise as a novel therapeutic Piezo1 inhibitor.

Cardiology news

Adult Congenital Heart Disease: Navigating Lifelong Care in an Evolving Health Landscape

By MedXY 10/07/2026

Adult congenital heart disease (ACHD) patients now outnumber affected children, shifting focus to lifelong management. Advances in specialized care, health systems, and digital innovations offer promising models to improve outcomes and equity in ACHD.

Cardiology news

Intracoronary imaging for left main PCI: key recommendations from the 2026 EAPCI–EBC clinical consensus

By MedXY 10/07/2026

A clear, clinician-focused summary of the 2026 EAPCI/EBC consensus recommending routine intravascular imaging (IVUS/OCT) to plan, guide and optimize left main bifurcation PCI — with practical steps, controversies and implementation advice.

Cardiology news Ophthalmology

Cholesteryl Ester Transfer Protein Inhibition: A Double-Edged Sword in Cardiovascular Health and Age-Related Macular Degeneration Risk

By MedXY 10/06/2026

Genetic analyses reveal that cholesteryl ester transfer protein (CETP) inhibition, while beneficial for cardiovascular disease, is associated with an increased risk of age-related macular degeneration (AMD) across European and East Asian populations, highlighting a critical safety concern.